There is 1 paper on FCAMR in aging research: none in people yet, 1 in animals.
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Alvin J. Siteman Cancer Center and 8 more
- 3 of 3 findings with company ties
- Animals1
Effects
3Body weight
upin mice1
1 study
Body weight
upin mice1
FCAMR increases body weight in mice (diabetic setting, kidney capsule or hindleg muscle transplantation).
“Additionally, mice receiving FCAMR-modified grafts into the kidney capsule or hindleg muscle maintained a higher body weight compared to controls in a diabetic setting.”
Animalsdiabetic setting, kidney capsule or hindleg muscle transplantation
Stem cells translational medicine
C-peptide
upin mice1
1 study
C-peptide
upin mice1
FCAMR increases C-peptide in mice (subcutaneous transplantation of SC-islets).
“Mice subcutaneously transplanted with SC-islets overexpressing FCAMR had reduced blood glucose levels and increased C-peptide compared to controls.”
Animalssubcutaneous transplantation of SC-islets
Stem cells translational medicine
Blood glucose
downin mice1
1 study
Blood glucose
downin mice1
FCAMR decreases blood glucose in mice (subcutaneous transplantation of SC-islets).
“Mice subcutaneously transplanted with SC-islets overexpressing FCAMR had reduced blood glucose levels and increased C-peptide compared to controls.”
Animalssubcutaneous transplantation of SC-islets
Stem cells translational medicine